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ABSTRACT
Human Papillomavirus (HPV) Vaccine: Understanding Individuals Not Vaccinating in the South
Using 2016 National Immunization Survey-Teen Data (NIS-Teen)
By
Saron Ephraim
May 1, 2018
INTRODUCTION: Human Papilloma Virus (HPV) is a highly contagious virus known to cause
many cancers in men and women. Vaccination for HPV has been available since 2006 but
coverage levels remain low with initiation rates at 60% and only 43% completion. The lowest
vaccination rates are found in the South.
AIM: This study aims to use data from the 2016 National Immunization Survey –Teen to
evaluate parental reasons for not vaccinating their teen for HPV among respondents in the
South. The study evaluated the demographic correlations of the top four reasons reported for
not vaccinating against HPV.
METHODS: Mantel-Haenszel χ2 test was done to assess possible differences for individuals
initiating HPV vaccination and those who had not by sociodemographic factors. Logistic
regression done evaluated several sociodemographic factors for top reasons for not
vaccinating. Analysis of the data was done using Statistical Analysis Systems 9.4.
RESULTS: The top four reasons given for not vaccinating for HPV were: 1) vaccine is not
needed/not necessary; 2) vaccine was not recommended; 3) concerns about vaccine
safety/side effects and 4) lack of knowledge about vaccine. Mother’s education, mother’s age,
race of teen, and gender were significantly associated with the top four reasons.
DISCUSSION: The results of this study imply specific sociodemographic factors are associated
with the top four reasons for declining HPV vaccine. Highly educated mothers were significantly
associated with the top four reasons for declining vaccine.
Keywords: Human Papilloma Virus (HPV), vaccination rates, southern states, not vaccinating for
HPV, HPV vaccine safety concerns/side effects
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Introduction
1.1 Background
Human Papilloma Virus (HPV) vaccination rates remain well below the 2020 Healthy
People goal of 80% in the United States. National coverage data from 2016 found that 60.4%
(65.1% of females; 56% of males) of teens had initiated the HPV series and only 43.4% (49.5% of
females; 37.5% of males) had completed all recommended doses (Walker et al., 2017).
Although the HPV vaccine has been around for over a decade, vaccine uptake remains low. The
South, as a region, had some of the lowest HPV vaccination rates in 2011 with 48.4% initiation
and 30.6% completion (Rahman, McGrath, & Berenson, 2014). National data shows that the
lowest HPV vaccine initiation and completion rates are in southern states with 47.8% initiation
in Mississippi and 30.8% completion in South Carolina (Walker et al., 2017). It has been well
established that HPV is a virus that causes many types of genital and oral cancers. There are an
estimated 19,400 women and 12,100 men who are affected by cancers cause by HPV annually
in the United States (Centers for Disease Control and Prevention [CDC], 2017). HPV infection is
responsible for 99.8% of cervical cancer and 90% of genital warts and cancer of the anogenital,
head and neck regions (Rahman et al., 2014). HPV is a very common virus and approximately
79 million Americans are currently infected with HPV and about 14 million new cases of HPV
infections occur each year (CDC, 2017).
The Food and Drug Administration (FDA) first licensed a vaccine in 2006 for use in
females age 9 through 26 ("FDA Licensure of Bivalent Human Papillomavirus Vaccine”, 2010)
and the Advisory Committee on Immunization Practices (ACIP) made a routine
recommendation for HPV vaccination for girls 11 to 12 years of age (up to age 26). In 2011 that

recommendation was extended to include boys up to age 21 (Seyferth, Bratic, & Bocchini,
2016). Low vaccine coverage is a public health concern because HPV is very common. Every
adult will eventually acquire HPV, even if it is a latent infection, at least once in their lifetime.
Previous research has found some trends in the possible explanation for the low uptake in HPV
vaccine. Many studies have shown that having a strong provider recommendation helps
improve vaccine initiation for HPV vaccine and that low uptake of HPV vaccine is due to a lack
of physician recommendation (Mohammed, Vivian, Loux, & Arnold, 2017). In addition, concerns
about safety and insufficient knowledge of HPV have been cited as sources for low uptake
(Mohammed et al., 2017). Other studies have suggested that completion is a challenge for this
vaccine despite having provider recommendation (Luque, Tarasenko, Dixon, Vogel, & Tedders,
2014). The rise in vaccine hesitant parents and parents who are electing to delay vaccinating
their children have also been offered up as an explanation for low uptake. Existing studies
looking at the low vaccine uptake have tried to understand why parents are choosing not to
vaccinate their children for HPV. Once the factors for refusing HPV vaccines are properly
understood, appropriate public health interventions can be implemented to improve health
outcomes. In the same effort, this study also aims to better understand the reasons provided by
parents for not vaccinating their teens for HPV in the South.

1.2 Purpose & Research Questions
The purpose of this study is to evaluate the main reasons for not vaccinating for HPV
within the 17 southern states using the 2016 National Immunization Survey –Teen data.
Because the South has the lowest initiation and completion rates for HPV vaccine, it is

beneficial to understand the nuances for the reasons given for not vaccinating among
individuals who are not vaccinating for HPV. The main research questions for this paper are:
1) What are the most common reasons provided for not vaccinating for HPV in the 17
southern states?
2) What are some of the sociodemographic factors that correlate with the top reasons
for not vaccinating?
3) Is there a relationship between gender, race, mother’s age, number of children
under 18 in the household, mother’s education and the reasons provided for not
vaccinating for HPV?
Based on existing research, the expected outcome is that the top reasons for not vaccinating
for HPV in the South will resemble the reasons provided at the national level. Older mothers
and those with higher education levels will be associated with the top reasons identified for
declining HPV vaccination. There may be additional variations in how demographic
characteristics correlate with the responses given for not vaccinating for HPV. Once the reasons
for declining HPV vaccination are better understood, more focused interventions can be
implemented to address concerns about HPV vaccine in the South.

Literature Review
2.1 Vaccine Coverage
In 2016, only 43.4% of adolescents (49.5% of females and 37.5% of males) between the
ages of 13 to 17 were up to date with their HPV vaccination series. These numbers were higher
for adolescents who had one or more doses of HPV, 61.1% for females and 56% for males
(Walker et al., 2017). Improvements in HPV coverage levels have been occurring but they have

been very gradual. In 2014, the initiation rate for HPV vaccine was 60% for females and 41.7%
for males (Reagan-Steiner et al., 2015). Between 2011 and 2012 there was no progress for
national HPV vaccination coverage rates for females ages 13 to 17 and a 3.3 percentage point
increase in 2014 (Reagan-Steiner et al., 2015). From 2015 to 2016 HPV vaccination initiation
rates and completion rates went up 4.3 percentage points and 2.2 percentage points
respectively (Walker et al., 2017). Other vaccines routinely administered for the same age range
as the HPV vaccine, Tdap and Meningococcal (MenACWY), both have higher vaccination rates
than HPV with 88% and 82.2% respectively (Walker et al., 2017). In general, other vaccines
routinely administered in the United States have had higher acceptance and completion rates;
most of these vaccine rates have reached or exceeded the 2020 Healthy People goals. Vaccine
initiation for HPV continues to slowly increase but remains 22 to 28 % points lower than those
for Tdap and ≥1 -dose MenACWY (Walker et al., 2017).
There are differences in coverage levels observed in different subgroups and geographic
regions for HPV vaccine. 2012 data showed that initiation rates for those that are older (19 to
26 years of age) were only 34.5% for females and 2.3% for males (Rahman, Islam, & Berenson,
2015). A study conducted by Rahman, Islam, and Berenson in 2015 found that HPV vaccination
rates did not differ by region for men but they did for women and the lowest rates of initiation
for women 19 to 26 were found in the South. Another study conducted by Rahman, McGarth,
and Berenson (2014) found similar trends for girls 13 to 17 years old with the lowest HPV
initiation and completion rates found in the South, 48.4% and 30.6% respectively. These low
coverage levels for HPV vaccination in the South signal a need to further understand the
reasons for the low uptake in this region of the country.

Race and income were found to be influential in initiation and completion rates among
boys. The odds were higher for initiating and completing HPV vaccines for boys who were on
Medicaid/SCHIP, boys who received a provider recommendation, boys from households with
incomes below the poverty threshold, boys who were Hispanic and boys who were NonHispanic Black (Henry, Swiecki-Sikora, Stroup, Warner, & Kepka, 2017). A study conducted by
Henry et al. (2017) found that the lowest initiation rates for HPV vaccination among boys were
in more affluent areas regardless of race/ethnicity. These disparities in HPV vaccination
initiation rates highlight potential targets for interventions aimed at improving vaccination
rates.

2.2 HPV Vaccination is Cancer Prevention
In the US, all cervical cancer and anal cancers in the population are attributable to HPV
infections (Seyferth et al., 2016). HPV infection causes most anogenital cancers as well as
oropharyngeal cancers which contributes to an estimated 600,000 cancer occurrences
worldwide and 250,000 premature deaths (Saraiya et al., 2015). There are currently three
different HPV vaccines licensed and available for use in the United States: the 4-valent HPV
vaccine which was first licensed in 2006 for use in women and in 2009 for use in men; the 2valent HPV vaccine licensed for use in only women in 2009; the 9-valent HPV vaccine which was
licensed in 2014 for use in both women and men (Seyferth et al., 2016). The ACIP has
recommended that adolescents between 11 to 12 years of age routinely receive HPV vaccine
and females 13 to 26 years and males 13 to 21 years who had not been previously vaccinated
receive vaccination for HPV (Petrosky et al., 2015). In 2016 the recommendation changed from

a three-dose series to a two-dose series depending on when the vaccine was first initiated
(Walker et al., 2017).
HPV vaccine has been shown to be effective and has contributed to reductions in the
prevalence of HPV. A study comparing pre- and post-vaccine era prevalence of HPV strains
found in the vaccine noted that there was a 56% decrease in prevalence among 14 to 19-yearold females (Markowitz et al., 2013). Not only has the vaccine been shown to help reduce the
prevalence of HPV included in the vaccine, it has also produced the appropriate immune
response among those vaccinated. A study conducted by Joura et al. (2015) demonstrated that
nearly 100% of women 16 to 26 years of age vaccinated with 9-valent HPV vaccine developed
antibodies of all the included strains in the vaccine within the first month after completing the
3-dose series. There are an estimated 31,500 newly diagnosed cancers in men and women
attributable to HPV and approximately 90% of these could be prevented with the receipt of the
9-valent HPV vaccine (Walker et al., 2017, p.881). In addition, the beneficial effects at the
population level for HPV vaccination can be observed as early as 3 years after the introduction
of an HPV vaccination program (Joura et al., 2015). The benefits of implementing an HPV
vaccination program and improving coverage levels help prevent cancer at the individual as
well as improve population health in a short timeframe.

2.3 Provider Recommendation
Many studies demonstrate the fundamental role provider recommendations have with
HPV vaccine initiation rates. In a study conducted by Mohammed et al. (2016) parents cited
that the main reason for not vaccinating their boys for HPV was the lack of a strong
recommendation from the provider. There have been many efforts to improve provider

recommendation of the HPV vaccination to patients but rates remain low. Mohammed et al.
(2017) used National Immunization Teen Survey data from 2014 and found that overall 72.6%
of girls and 51.8% of boys received a provider recommendation of HPV vaccination. Provider
recommendation is one of the most important predictors of HPV vaccine uptake among
adolescents and if patients are not receiving recommendations the likely outcome will be low
vaccine utilization.
There is also evidence showing that among parents of teen girls surveyed only 29% were
given HPV recommendations that aligned with current national guidelines (Lindley et al., 2016).
This implies that despite providers’ making recommendations, few may be making the
recommendation in line with the ACIP guidelines. The deviation from the national guidelines for
HPV vaccination leads to variation in who is receiving a recommendation. Girls have a 2.57
higher odds of receiving provider recommendations for HPV vaccines than boys, which points
to the bias associated with lower recommendation for boys (Mohammed et al., 2016).
Variations in the way providers make recommendations have also been observed for
different racial and ethnic groups. A study conducted by Burdette, Webb, Hill, & JokinenGordon (2017) found that provider recommendations among males and females varied by race
and ethnicity. Approximately 52% of African American females received a recommendation
compared to 61% among non-Hispanic White females (Burdette, Webb, Hill, & Jokinen-Gordon,
2017). This study also found that race and ethnic disparities in HPV vaccination rates among
males are heavily influenced by differences in provider recommendations. For females,
minority girls have seen a higher increase in provider recommendations and HPV vaccination
uptake compared to non-Hispanic Whites (Burdette et al., 2017). Luque, Tarasenko, Dixon,

Vogel, & Tedders (2014) showed that only “46% of Georgia Vaccines for Children (VFC)
providers who saw 11 to 12-year-old female patients, always made a recommendation for HPV
vaccination. Similarly, Texas had 48% of the physicians reporting that they had always
recommended HPV vaccination for female patients between 11 to 12 years old (Tarasenko,
Dixon, Vogel, & Tedders, 2014).
Other researchers have found similar variations in the rate of vaccine recommendations
made by providers based on the teen’s demographic factors. Among boys, the lowest vaccine
recommendation rates were found for those living in the South (43.7%), those living below the
poverty line (49.4%), and for those with mothers having less than a high school education
(44.8%) (Mohammed et al., 2016). The lowest recommendation rates for females were
observed among Hispanics (69.2%), living in the South (69.1%), those living below the poverty
line (64.9%), and those with mothers whose education level was less than high school
education (61.9%) (Mohammed et al., 2016). Since provider recommendation is an important
factor in the uptake of HPV vaccines these variations in recommendation can contribute to the
variation in uptake among different subgroups. Adolescent boys and girl living in the South had
lower odds of vaccine recommendation compared to those living in the Northeast, Midwest,
and West (Mohammed et al., 2016). Vaccination coverage for females with ≥1-dose of HPV was
lowest in Mississippi with 47.9% and up-to-date estimates for females was lowest in South
Carolina with 30.8% (Walker et al., 2017). The literature suggests that those residing in the
South are receiving recommendations for HPV at lower rates which may be influencing the
trend in low HPV vaccination initiation and completion in this region.

In addition to the importance of the provider’s recommendation, the providers’ vaccinerelated attitudes are also strongly associated with the parents’ attitudes about vaccinations
(Mergler et al., 2013). A study conducted by Salmon et al. (2008) found that most Primary
Health Care Providers (PHCPs) identified by children exempt from school immunization
requirements and those children without school immunization exemptions had similar attitudes
concerning vaccinations. There was a striking difference found between PHCP of children with
vaccine exemptions regarding immunization safety beliefs. The study findings show that the
knowledge, attitudes, and practices of PHCPs may be a contributing factor on the parent’s
decisions to decline or accept vaccinations (Salmon et al., 2008). Mergler et al. (2013) also
found that guardians had 45 times higher odds of agreeing that there were community benefits
to having children fully vaccinated when their provider agreed, compared to guardians whose
providers did not agree. The acceptance of vaccines by parents is not simply based on provider
recommendation but also related to the providers attitude about vaccinations.

2.4 Who’s Refusing to Vaccinate & Why?
A study conducted by Cheruvu, Bhatta, and Drinkard (2017) looked at those who had no
intentions to vaccinate for HPV over several study periods using NIS-Teen data and found very
distinct characteristics for those not vaccinating. Parents in the survey years 2009 to 2012 were
significantly more likely to report ‘no intent’ to vaccinate for HPV and cite safety and
effectiveness concerns as their reason for not vaccinating for HPV compared to parents
surveyed in 2008 (Cheruvu, Bhatta, & Drinkard, 2017). This study also found that, for
unvaccinated females, three out of five parents reported that they had no intentions to
vaccinate their daughters in the next 12 months. There were also some sociodemographic

factors associated with the parents’ intention to not vaccinate for HPV. Factors associated with
parents’ decision to not vaccinate their daughters included: the number of people in the
household, annual household income of $35,001 - $75,000, mothers with higher than high
school education, and mother’s over 45 years of age (Cheruvu et al., 2017). A similar study that
looked at parents’ intent to vaccinate for HPV found that for parents of US adolescents (13 to
17), maternal education was the strongest predictor of intent to obtain HPV vaccination for
their teen (Mohammed et al., 2017). Among parents of adolescent boys, mother’s marital
status, and non-Hispanic black race/ethnicity were significant predicators of intention to obtain
HPV vaccination (Mohammed et al., 2017).
Similar trends were found among those initiating the HPV vaccination series. For boys,
racial/ethnic minorities and those in the VFC program had higher rates of initiation whereas
boys with highly educated mothers were less likely to be fully immunized (Johnson, Lin, Cabral,
Kazis, & Katz, 2016). Using data form NIS-Teen a study conducted by Johnson et al. (2016)
revealed several reasons parents provided for refusing to vaccinate their teens for HPV: vaccine
was not recommended, vaccine was not needed, lack of knowledge, safety concerns, and the
teen was not sexually active. There were also differences in reasons for vaccine refusal based
on the gender of the child. Parents/guardians of male children were significantly more likely to
indicated that the vaccine was not recommended by the provider and that the vaccine was not
necessary; whereas parents/guardians of girls were significantly more likely to report concerns
for vaccine safety (Johnson et al., 2016). Challenging the results of previously cited studies, this
study also found that provider recommendation was not associated with completion of the
three-dose series indicating that although provider recommendation is important there may be

other factors associated with completion of the series (Johnson et al., 2016). There were also
some characteristics that made individuals immune to provider recommendations. Even though
providers were more likely to recommend the vaccine to girls who had mothers with higher
education levels, these mothers were immune to the recommendations from the provider
(Johnson et al., 2016). Provider recommendation may be important but there are other factors
that influence the decision of caregivers to get the HPV vaccine for their teen.
Thompson, Rosen, Vamos, Kadono, & Daley (2017) conducted an analysis of NIS-Teen
data from 2012 to 2015 to evaluate the reasons provided for not vaccinating for HPV and found
that the most common reason for non-vaccination among males was lack of recommendation
in years 2012 and 2013. However, in 2014 and 2015 the most common reason was that the
vaccine was not needed. For females, the most common reason for not vaccinating was that
the vaccine was not needed for all survey years. These studies demonstrate that there is still a
gap in knowledge among parents about the importance and need for HPV vaccination.

2.5 Vaccine Hesitancy
Vaccine hesitancy has been around since vaccines were first developed and individual
hesitancy to vaccinate has been an ongoing concern for the healthcare community (Patel &
Berenson, 2013; Siddiqui, Salmon, & Omer, 2013). The success of vaccine programs have led to
a shift in fear from vaccine-preventable diseases to the fear of the vaccines that prevent those
diseases (Siddiqui et al., 2013). Many who are electing to not vaccinate tend to be older
mothers (≥30 years old), college educated and tend to be living in higher income households
(Siddiqui et al., 2013). Vaccine Hesitant Parents (VHP) believe that children receive too many
vaccines, that their child may have serious side effects from vaccines, and that vaccines may

negatively impact their child’s immune system (Williams, 2014). Most barriers to vaccinate for
VHP are centered around concerns about vaccine safety (Williams, 2014). Results from studies
evaluating the demographic information of parents who tend to refuse vaccines revealed that
parents who refuse tend to be more educated whereas those who accept vaccination have a
lower education level (Patel & Berenson, 2013).
The literature suggests that the low uptake of HPV vaccine is also connected to safety
concerns, and inadequate knowledge about HPV (Mohammed et al., 2017). National
Immunization Survey from 2003 found that 21.8% of parents intentionally delayed vaccine
doses and that these parents reported vaccine safety concerns as reasons for the delay
(Salmon, Dudley, Glanz, & Omer, 2015). A systematic literature review conducted by Holman et
al. in 2014 found that parents were aware of the HPV vaccine but expressed the need for more
information before they decided to vaccinate their children and cited lack of knowledge as a
barrier (Holman et al., 2014). Holman et al. (2014) also found that parents reported having
concerns about adverse effects and vaccine safety which were hinderance for vaccine uptake.
A focus group conducted by Sanders Thompson, Arnold, and Notaro (2012) of African
American parents also uncovered similar findings of the need for more education on HPV
vaccinations and the reasons that HPV vaccination is recommended at younger ages. The semistructured interview of 30 participants was conducted after initial interviews involving two
hundred African American men and women about their attitudes towards HPV vaccination.
There were six major themes identified as influencing parental decisions about HPV vaccination
and those included: the influence of physician recommendation, vaccine decision making,
desire for information related to vaccine safety, youth sexuality, HPV vaccine costs, and

religious issues affecting HPV vaccination decisions (Sanders Thompson et al., 2012). The
researchers found that although this group was religious, religion did not appear to be a barrier
to HPV vaccination and these parents were not concerned that HPV vaccination would lead to
early sexual activity (Sanders Thompson et al., 2012). The findings by Sanders Thompson et al.
did show that there were concerns about vaccine safety, cost, and age of vaccination. Despite
the concerns there was a desire to receive more information on these topics. Another
important finding to note from this study was the suggestion that parents were not aware of
the reasons for the targeted ages for HPV vaccination which aligned with previous studies. If
parents are not clear on the need to vaccinate adolescents 11 to 12 years for HPV then they will
decline the vaccine on the basis that it is not needed or necessary (Sanders Thompson et al.,
2012). It is important to understand the perceptions parents have of HPV vaccination, their
concerns, and gaps in knowledge; this will inform tailored interventions to improve vaccine
uptake and sufficiently address parents’ concerns.
In addition to concerns about safety, attitudes about HPV vaccination and actual choices
about vaccinating for HPV can be conflicting. A United States national assessment of parental
attitudes about male HPV vaccination found that 90% of parents agreed that male HPV
vaccination was generally but only about half of parents of boys planned to have their own sons
vaccinated against HPV as adolescents (Dempsey, Butchart, Singer, Clark, & Davis, 2011).
Although parents perceived HPV vaccination as a good thing there was a disconnect when it
came time to vaccinating their own child. This disconnect demonstrates the potential
breakdown in public health messaging about HPV and the way parents receive these messages.

In 2009, the Association of State and Territorial Health Offices (ASTHO) commissioned a
survey to collect information about effective messages and materials to address parental
concerns about vaccinations. The results of the survey showed that a strong majority of parents
supported vaccinations but had concerns about their safety and possible adverse effects
(Association of State and Territorial Health Offices [ASTHO], 2010). The survey also evaluated
vaccine acceptance and found that 16% of parents had refused vaccine for their children. Of
those refusing vaccines 6% are considered “minor refusers” who decline Hep A, HPV, or flu
vaccines; 10% are considered “significant refusers” who refuse one or more routinely
recommended childhood vaccines (ASTHO, 2010). Another 5% of parents and guardians have
major concerns about vaccinating their children yet they have not refused a vaccine (ASTHO,
2010). The survey found that the most frequently refused vaccine was HPV. The findings of the
ASTHO commissioned survey demonstrate the persistent concerns from parents about
vaccines, even among those who choose to vaccinate.

2.6 Policy Interventions
49.8% of adolescent males and 62.8% of females had one or more doses of HPV vaccine
in 2015 but 81.3% had received Tdap and 87.1% had received meningococcal conjugate (MVC4)
vaccine (Thompson, Rosen, Vamos, Kadono, & Daley, 2017, p. 289). These numbers suggest
that HPV vaccination rates continue to linger behind those of Tdap and MCV4 indicating that
there is something specifically unique about the perceptions of HPV vaccination that is leading
to the slow uptake. Due to this finding, many states have attempted to pass legislative and
policy level interventions with the attempt to increase uptake. A study conducted by Perkins,
Lin, Wallington, and Hanchate (2016) used NIS-Teen data for survey years 2009 to 2013

evaluated vaccination rates among girls residing in states and jurisdictions with school-entry
mandates for HPV and those in states with educational mandates. The study found that laws
passed to improve HPV vaccination rates did not result in higher vaccine coverage in states and
jurisdictions with mandates compared to those without (Perkins, Lin, Wallington, & Hanchate,
2016). It concluded that before considering legislation, policies should focus on getting
providers to give strong, consistent recommendations to prevent skepticism and hesitancy
among parents (Perkins, Lin, Wallington, & Hanchate, 2016).
Another study by Sadaf, Richards, Glanz, Salmon, and Omer (2013) conducted a
systematic review of interventions to reduce vaccine refusal and hesitancy. The findings from
this study did not reveal any evidence on effective interventions to address parental vaccine
hesitancy and refusal. Sadaf et al. (2013) discussed the need to develop interventions that can
influence parents’ perceptions about vaccines and the need for research focused on changing
behavior. As vaccine refusals grows, policy makers should seek interventions that can improve
vaccination rate among parents who normally refuse vaccinations (Sadaf, Richards, Glanz,
Salmon & Omar, 2013). The need to address the concerns of parents who are hesitant about
vaccinating for HPV is imperative in order to improve vaccine coverage in the United States.
Increasing HPV vaccination coverage will help reduce the burden of disease caused by HPV.
Vaccine recommendation, although important, is not being given consistently. HPV
vaccination rates continue to fall behind other adolescent vaccination rates. The lowest
initiation and completion rates for HPV vaccine are found in the South. And mothers that are
older, white, with college education, and more affluent tend to be the ones not vaccinating.
Concerns about vaccine safety, not understand why HPV vaccine is administered between 11 to

12 years, and a general lack of awareness of how the immune system works in conjunction with
vaccines have led to the low uptake in HPV vaccination. Fully understanding similar possible
trends in the South will help improve education efforts aimed at improving vaccination
coverage levels for HPV.

Methods & Procedures
3.1 National Immunization Survey –Teen 2016 (NIS-Teen)
NIS-Teen is an annual survey conducted by the National Center for Immunization and
Respiratory Diseases and the National Center for Health Statistics of the Centers for Disease
Control and Prevention. NIS-Teen uses a two-phase method of collecting a large national
probability sample of teens aged 13 to 17 years of age. The sample includes households in the
50 states, the District of Columbia, and the U.S. Virgin Islands. The first phase involved a
random digit dialing (RDD) telephone (landline and cell phone numbers) survey to identify
households with age-appropriate teens. Once a household was identified the adult with the
most knowledge about the teen’s immunization history was interviewed. In the second phase
providers identified as having administered vaccinations to the teen were mailed surveys to
collect information about the immunization history of the teen. The 2016 dataset had a total of
41,994 completed household interviews. Detailed methods for sampling for the NIS-Teen 2016
are available for review (National Center for Immunization and Respiratory Diseases, 2017).
NIS-Teen 2016 was deidentified and made available for use as a public dataset.

3.2 Sample
This study used a subset sample (n=16,125) of all respondents residing in the 17 states
that are part of the South region as defined by the United States Census Bureau. The 17 states

are Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana,
Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia,
and West Virginia (U.S. Census Bureau, n.d.). From the 16,125 respondents in the south,
another subset was taken from the data for those who had a “yes” or “no” response to the
question asking if the teen had any doses of HPV vaccine (n=14460). Only the household survey
portion of NIS-Teens was used for this study.

3.3 Reasons for not Vaccinating for HPV
Respondents of the household survey were asked several questions about HPV
vaccination in relation to the selected teen. The parent or guardian was asked “has the teen
ever received HPV shots?” and parents could respond yes, no, or don’t know. Those who
responded with a “no” were asked a follow up question about their intentions to have the teen
vaccinated. The question asked, “how likely is it that the teen will receive HPV shots in the next
12 months?”. Parents who responded, “very likely” or “somewhat likely” were considered to
have intentions to vaccinate their teen. Those who responded, “not too likely”, “not likely at
all”, or “not sure/don’t know” were considered to be parents who had no intention to vaccinate
their teen for HPV vaccine. These parents were asked follow-up questions about the main
reasons for choosing not to vaccinate in the next 12 months. Respondents had an option to
select the main reason from 14 possible options. If the parent provided more than one reason
they were asked “what would you say is the MAIN reason?”. For the analysis, the following
reasons were selected to be evaluated for the subgroup that was defined as having no intention
to vaccinate for HPV:

•

vaccine was not recommended

•

safety concerns/side effects

•

not needed/not necessary

•

religion/orthodox

•

don’t believe in immunizations

•

more info/new vaccine

•

lack of knowledge

•

not a school requirement

•

[teen] not sexually active

•

increased sexual activity concerns

•

not appropriate age

•

child is male

3.4 Statistical Analysis
The sample size (n=14460) consisted of those who responded “yes” or “no” to the
question that asked, “has the teen received HPV shots?”. A univariate analysis was conducted
to test for differences between those who responded “yes” or “no” to the question by
sociodemographic factors (age of teen, gender of teen, relationship of respondent to teen,
mother’s age, mother’s education level, marital status of mother, housing, poverty status and
the number of children under 18 in the household). The sociodemographic factors were
selected based on what was available in the household survey and based on what was found in
the literature for factors associated with declining HPV vaccination. A similar univariate analysis
was done to test the relationship between respondents that answered “yes” or “no” and the
states in which they resided. These tests were used to determine if there were difference
among those who started vaccinating for HPV and those who did not by different
sociodemographic factors. The p-values were calculated with 95% confidence intervals and
statistical significance was defined as a p-value of < 0.05.
Frequencies were calculated for the 12 main reasons provided for not vaccinating for
HPV among respondents who were defined as having no intention to vaccinate. Those who
answered “yes” or “no” to the 12 reasons were included in calculations for the frequencies

(n=5824). The top four reasons provided were identified and further frequency distributions
were evaluated for these top four reasons and sociodemographic factors including the gender
of the teen, mother’s age, relationship of respondent to teen, and the number of teens under
18 in the household.
A logistic regression analysis was performed for each of the top four reasons given for
not vaccinating for HPV. The dependent variable was the response of “yes” to the reason for
not vaccinating for HPV; meaning the respondent agreed that the reason selected was the main
reason for electing not to vaccinate their teen for HPV in the next 12 months. The following
independent factors were included in the model the gender of teen, mother’s age, mother’s
education level, the number of children under 18 in household, race/ethnicity, and the
relationship of respondent to the teen. These factors were included in the model because of
existing evidence in the literature that showed connections with these factors and intention to
vaccinate for HPV. The model was tested four different times for the top four different reasons
for not vaccinating. All analysis was done using Statistical Analysis Systems 9.4.

Results
4.1 Sample Characteristics
Table 1 has the distribution of HPV vaccination status for teens 13 to 17 among the
southern states included in this study. Statistical significance was found between those
answering “yes” or “no” to having a dose of HPV and the state of residence of the teen. This
indicates that there is a difference between those who had started their HPV vaccination and
those who had not started by state of residence.

Table 1: HPV Vaccination Status by State of Residence
*True State of Residence of
Teen

n=14460
# (%)

HPV Dose
Yes (%)

HPV Dose
No (%)

Alabama
Arkansas

608 (4.2)
638 (4.4)

283 (46.6)
290 (45.4)

325 (53.5)
348 (54.6)

Delaware
District of Columbia

677 (4.7)
725 (5.0)

392 (57.9)
505 (69.7)

285 (42.1)
220 (30.3)

Florida
Georgia

764 (5.3)
679 (4.7)

381 (49.9)
357 (52.6)

383 (50.1)
322 (47.4)

Kentucky

578 (4.0)

262 (45.3)

316 (54.7)

Louisiana
Maryland

626 (4.3)
843 (5.8)

300 (47.9)
535 (63.5)

326 (52.1)
308 (36.5)

Mississippi
North Carolina

618 (4.3)
695 (4.8)

250 (40.5)
357 (51.4)

368 (59.6)
338 (48.6)

Oklahoma
South Carolina

581 (4.0)
629 (4.4)

268 (46.1)
283 (45.0)

313 (53.9)
346 (55.0)

550 (3.8)
3822 (26.4)

261 (47.5)
1853 (48.5)

289 (52.6)
1969 (51.5)

826 (5.7)
601 (4.2)

456 (55.2)
318 (52.9)

370 (44.8)
283 (47.1)

Tennessee
Texas
Virginia
West Virginia

* State FIPS Code used.
Mantel-Haenszel Chi-square test was used to calculate p-values using 95 % confidence interval (CI) for the difference between those answering yes or no to having HPV doses among
teen’s true state of residence n= 14460(those with responses of Don’t Know and unknown were removed from the calculation of this value).All values in table are statistically significant
with p-value = 0.0003.

Table 2 provides demographic characteristics of adolescents 13 to 17 years of age who either
had received a dose of HPV vaccine or who had not started the series. There was statistically
significant difference found between those having received a dose of the HPV vaccine and
those who had not for seven of the sociodemographic factors selected. Age of teen, gender of
teen, relationship of respondent to teen, mother’s age, mother’s education level, and marital
status of mother all had statistically significant p-values indicating a difference between those
who had started HPV vaccination and those who had not. There is correlation between the
selected sociodemographic factors and initiation of HPV vaccination.

Table 2: Characteristics of NIS-Teen 2016 Respondents Residing in the South by Vaccination Status
n=14460
Number(%)

HPV Dose?
Yes (%)

HPV Dose?
No (%)

13

2927 (20.2)

1327 (45.3)

1600 (54.7)

14
15
16
17

2872 (19.9)
2932 (20.3)
3060 (21.2)
2669 (18.5)

1415 (49.3)
1516 (51.7)
1637 (53.5)
1456 (54.6)

1457 (50.7)
1416 (48.3)
1423 (46.5)
1213 (45.5)

7429 (51.4)
7031 (48.6)

3390 (45.6)
3961 (56.3)

4039 (54.4)
3070 (43.7)

Participant Characteristics

<.0001

*Age of Teen

<.0001

Gender of Teen
Male
Female

0.9211

Race/Ethnicity of Teen
Hispanic
Non-Hispanic White Only
Non-Hispanic Black Only
Non-Hispanic Other + Multiple Race

2579 (17.8)
8063 (55.8)
2425 (16.8)
1393 (9.6)

1411 (54.7)
3899 (48.4)
1328 (54.8)
713 (51.2)

1168 (45.3)
4164 (51.6)
1097 (45.2)
680 (48.8)

Mother (step, foster, adoptive)/Female Guardian

9653 (66.8)

5169 (53.55)

4484 (46.5)

Father (step, foster, adoptive)/Male Guardian
Grandparent

3662 (25.3)
600 (4.2)

1655 (45.19)
315 (52.50)

2007 (54.8)
285 (47.5)

540 (3.7)

210 (38.89)

330 (61.1)

1 (0.0)
4 (0.0)

-2 (50.0)

1 (100)
2 (50.0)

0.0002

Relationship of Respondent to Teen

Other Family Member/Friend
Don’t Know
Refused

0.0205

Mother’s Age Category
≤ 34 Years

1387 (9.6)

721 (52.0)

666 (48.0)

34 to 44 Years

6249 (43.2)

3054 (48.9)

3195 (51.1)

≥ 45 Years

6824 (47.2)

3576 (52.4)

3248 (47.6)
0.0353

Mother’s Education Level
Less than 12 Years
12 Years
More than 12 Years, Non-College Graduate
College Graduate

1529 (10.6)
2473 (17.1)
3758 (26.0)
6700 (46.3)

791 (51.7)
1203 (48.7)
1848 (49.2)
3509 (52.4)

738 (48.3)
1270 (51.4)
1910 (50.8)
3191 (47.6)

9914 (68.6)
4546 (31.4)

4861(49.0)
2490 (54.8)

5053 (51.0)
2056 (45.2)

<.0001

Mother’s Marital Status
Married
Never Married/Widowed/Divorced/
Separated/Deceased/Living with Partner

0.2441

Housing
Owned or Being Bought
Rented
Other Arrangement
Don’t Know
Refused

10345 (71.5)
3602 (24.9)
357 (2.5)
20 (0.1)
136 (0.9)

5237 (50.6)
1867 (51.8)
175 (49.0)
10 (50.0)
62 (45.6)

5108 (49.4)
1735 (48.2)
182 (51.0)
10 (50.0)
74 (54.4)
0.3758

**Poverty Status
Above Poverty > $75,000
Above Poverty ≤ $75,000
Below Poverty
Unknown

6431 (44.5)
4653 (32.2)
2432 (16.8)
944 (6.5)

3282 (51.0)
2256 (48.5)
1368 (56.3)
445 (47.1)

3149 (49.0)
2397 (51.5)
1064 (43.8)
499 (52.9)
0.3550

Number of Children under 18 in House Hold
One
Two or Three
Four or More

p-value ⱡ

5701 (39.4)
7419 (51.3)
1340 (9.3)

2815 (49.4)
3903 (52.6)
633 (47.2)

2886 (50.6)
3516 (47.4)
707 (52.8)

*Age of teen at time of interview
** Based on the 2015 census poverty threshold; based on exact income if given or any established income bound
ⱡ Mantel-Haenszel Chi-square test was used to calculate p-values using 95 % confidence interval (CI) for the association between teen’s sociodemographic factors and the difference of answering
yes or no to having any doses of HPV. n= 14460(those with responses of Don’t Know and unknown were removed from the calculation of this value).

4.2 Distribution of Reasons for Not Vaccinating for HPV
Frequency distributions for the 12 reasons for not vaccinating for HPV can be found in
Figure 1. The distribution of reasons for not vaccinating ranged from 0.4% citing
“religion/orthodox” to 20.7% citing “vaccine as not needed/not necessary” among those with
no intention to vaccinate for HPV. The top four reasons for not vaccinating for HPV were:
vaccine not needed/not necessary (20.7%), not recommended (16.7%), safety concerns/side
effects (16.2%) and lack of knowledge (12.3%).
Figure 1: Distribution of Reasons for not Vaccinating Among Those not Intending to Vaccinate (n=5824)
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4.3 Top Four Reasons for Not Vaccinating for HPV
The distribution of sociodemographic information for the top four reasons for not
vaccinating for HPV vaccine highlight interesting trends. Figures 2 through 5 show the
distribution of the top four reasons by different sociodemographic factors. Those who
answered “yes” for the top four reasons were divided out by gender of teen and age of mother.

Approximately over 80% of those electing not to vaccinate because of the top four reasons had
mothers over the age of 34. Less than 15% of the respondents electing not to vaccination due
to the top four reasons had mothers who were 34 years old or younger. This was the case for
both male and female teens. Those declining to vaccinate for HPV due to the top four reasons
tend to be teens with older mothers.
Figure 2: Reasons for not Vaccinating by age of Mother for Male Teens
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Figure 3: Reasons for Not Vaccinating by Age of Mother for Female Teens
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Mothers tended to be 45 years or older for those choosing not to vaccinate for HPV because
“vaccine was not needed/not necessary” or because “vaccine was not recommended”. A
slightly larger percentage of those not vaccinating because of “safety concerns/side effects” or
“lack of knowledge” had mothers between the ages of 35 to 44. Those who declined HPV
vaccination were likely to be teenagers with older mothers. This finding aligns with what was
found in the literature; mothers of teens not vaccinated for HPV tend to be older.
Figure 4 shows the top four reasons given for not vaccinating by the relationship of the
respondent to the teen. More mothers/female guardians responded with the top four reasons
for not vaccinating their teen for HPV. 75.4% of those who responded that “safety
concerns/side effects” were the main reason for not vaccinating for HPV were mothers/female
guardians of teen.

Figure 4: Reasons for Not Vaccinating for HPV by Respondent’s Relation to the Teen
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Among those who selected “vaccine not recommended” as the reason for not vaccinating for
HPV, 37.9% were fathers/male guardians. Figure 5 shows the breakdown of those who
answered with the top four reasons by the number of teens under 18 in the household.
Figure 5: Number of Teens Under 18 in Household by Top Four Reasons for Not Vaccinating
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The smallest proportion of those not vaccinating due to the top four reasons had households
with 4 or more teens under 18. The bulk of those responding with the top four reasons for not
vaccinating for HPV had households with 2 or 3 teens under the age of 18. Among those who
said they would not vaccinate for HPV because it was “not needed/not necessary”, 51.6% had
households with 2 or 3 children under the age of 18. 47% of those who elected to not vaccinate
for HPV because the vaccine was not recommended had households with 2 or 3 children under
the age of 18. For those who did not vaccinate because of “safety concerns/side effects” or
because of “lack of knowledge”, 50.3% and 49.4% respectively, were families with 2 or 3
children under the age of 18 in the household. This may indicate that the number of children
under 18 in the household may impact the decision to vaccinate for HPV. It’s conceivable that
that parents with more children may have had more exposure to recommendations for HPV
vaccination due to more encounters with healthcare professionals.

4.4 Sociodemographic Factors & Top Four Reasons for Not Vaccinating for HPV
All odds ratio estimates for sociodemographic factors tested for association with top
four reasons for not vaccinating in the model can be found in the appendix. Table 3 has all the
statistically significant sociodemographic factors associated with the top four reasons for not
vaccinating in the South.

Table 3: Characteristics Associated with Top Reasons for not Vaccinating
Reasons for Not Vaccinating for HPV
Point
Estimate

95% Wald Confidence Limits

Characteristics for “Not needed/Not necessary”
Mom’s age between 35 - 44
Relation of Respondent to teen being mother/female guardian

0.74
0.83

0.57 - 0.96
0.72 - 0.97

Characteristics for “Vaccine not recommended”
Gender of Teen Being Male
Mother having more than 12 yrs non-college education
Mother being a college graduate
Relation of respondent to teen being mother/female guardian

1.21
0.80
0.63
0.65

1.03 - 1.42
0.65 - 0.98
0.52 - 0.76
0.55 - 0.76

Characteristics for “Safety Concerns/Side Effect”
Gender of Teen Being Male
Mother having more than 12 yrs non-college education
Mother being a college graduate
Relation of respondent to teen being mother/female guardian
Race Being White

0.64
1.39
1.45
2.05
1.49

0.55 - 0.74
1.11 - 1.74
1.17 - 1.79
1.70 - 2.46
1.19 - 1.86

Characteristics for “Lack of Knowledge”
Gender of Teen Being Male
Mother having more than 12 yrs non-college education
Mother being a college graduate
Only one child <18 yrs in household
Two or three children <18 yrs in household
Relation of respondent to teen being mother/female guardian

1.39
0.79
0.57
1.87
1.70
0.83

1.16 - 1.67
0.56 - 0.89
0.46 - 0.71
1.29 - 2.72
1.19 - 2.43
0.69 - 0.99

*All odds ratios on this table were statistically significant.

Several sociodemographic factors were found to be statistically significant in influencing
the decision to not vaccinate because of the reason “vaccine is not needed or not necessary”.
Mothers between the ages of 35 to 44 were 26% less likely to answer that the main reason for
not vaccinating was because HPV vaccine was “not needed/not necessary” when compared to
mothers who were 34 years old or younger. Mothers or female guardians were 17% less likely
to decline HPV vaccination because it was “not needed/not necessary” when compared with
fathers or male guardians.
Factors in the model that were found to be statistically significant with answering that
“vaccine not recommended” was the main reason for declining HPV vaccination were: the
gender of the teen being male, the relation the respondent to teen being mother/female
guardian, the mother having higher than 12 years non-college education, and the mother
having college education. Those who were male teens were 21% more likely to not vaccinate

for HPV because vaccine was not recommended when compared to female teens. Teens whose
mothers had 12 years or more non-college education were 20% less likely to indicate that the
reason for not vaccinating for HPV was “vaccine not recommended” when compared with teens
whose mothers had high school or lower level education. Teens with mothers who were college
graduates were 37% less likely to say they did not vaccinate for HPV because it was “not
recommended” when compared with teens whose mothers had a high school or lower level
education. Teens whose mothers had higher education levels were less likely to have provided
the reason, “vaccine not recommended”, as the main reason for not vaccinating for HPV.
Mohammed et al. (2016) also found that teens with mothers who had lower education levels
received the lowest recommendation rates for HPV. The literature supports what was found in
this model. Mothers or female guardians were 35% less likely to say the main reason for not
vaccinating was “vaccine not recommended” when compared to fathers or male guardians. This
indicates that fathers or male guardians are not vaccinating their teens because vaccines are
not being recommended to them.
For individuals who answered that the main reason for not vaccinating for HPV was
because of “safety concerns/side effects”, the following factors were found to be statistically
significant with this response: gender of the teen being male, mother having 12 years or more
non-college education, mother being a college graduate, respondent being the mother or
female guardian of the teen, and race of teen being white. Male teens were 37% less likely than
female teens to indicate that “safety concerns/side effects” were the main reasons for not
vaccinating. Teens with mothers who had more than 12 years non-college education were 39%
more likely to indicate that safety concerns or side effects were the main reason for not

vaccinating for HPV when compared with teens whose mothers had high school or lower level
education. Teens with mothers who were college graduates were 45% more likely to indicate
that HPV vaccine was declined because of “safety concerns/side effects”. Mothers or female
guardians were 2.05 times more likely to indicate “safety concerns/side effects” were the main
reason for not vaccinating when compared to fathers or male guardians. White teens were 49%
more likely to say, “safety concerns/side effects” were the main reason for not vaccinating
when compared with black teens. The education level of the mother shows up again with this
reason and teens whose mothers have higher education were more likely to indicate “safety
concerns/side effects” as the main reason for not vaccinating their teen for HPV.
For respondents who answered that the main reason for not vaccinating for HPV was
due to “lack of knowledge”, the following factors were found to be statistically significant:
gender of teen being male, mother having more than 12 years non-college education, mother
being a college graduate, only having one child under 18 in the household, having 2 or 3
children under 18 in the household, and the respondent being the mother or female guardian
to the teen. Male teens were 39% more likely to have “lack of knowledge” be the reason that
was given for not vaccinating when compared to female teens. Teens whose mother had more
than 12 years non-college education were 21% less likely to indicate that lack of knowledge was
the reason for not vaccinating for HPV. Meanwhile teens with mothers with college education
were 43% less likely to indicate lack of knowledge as a reason for not vaccinating for HPV when
compared to mothers with high school or lower level of education. Teens in households with
only one child under 18 were 87% more likely to indicate lack of knowledge as the reason for
not vaccinating when compared with households with 4 or more children under the age of 18.

Families with 2 or 3 children under 18 were 70% more likely to indicate lack of knowledge was
the main reason for not vaccinating when compared with families with 4 or more children
under 18. Mothers or female guardians were 18% less likely to say lack of knowledge was the
main reason for not vaccinating when compared to fathers or male guardians. These findings
indicate that mother’s higher education level was a protective factor against selecting lack of
knowledge as the reason for not vaccinating. Smaller household size seems to indicate a higher
chance of not vaccinating for HPV because of lack of knowledge.
All four reasons for choosing not to vaccinate for HPV had some statistically significant
finding for the respondent being the mother/female guardian of the teen. This indicates that
the relationship of the respondent to teen has some influence on choosing not to vaccinate for
HPV due to the top four reasons. In three of the top four reasons, there was consistent
statistical significance among these factors: mother’s education level being higher than high
school and gender of the teen. Household size was only found to be statistically significant for
the response of “lack of knowledge” as the reason for not vaccinating. Households with one,
two or three children under the age of 18 were more likely to cite lack of knowledge as the
main reason for not vaccinating for HPV.

Discussion
5.1 Discussion & Limitations
The findings in this study echo previous published literature. Teens in the south are not
vaccinating for many of the same reasons found by researchers looking at national data. The
respondent being the mother or female guardian was found to be statistically significant for the
top four reasons for not vaccinating. This is worth noting because mothers/female guardians

serve as the influential decisionmakers regarding their teens receiving HPV vaccination.
Because mothers/female guardians are sort of gatekeepers for their teens it is important to
address the concerns that they are most worried about. Mothers were also 2.05 times more
likely to indicate, “safety concerns/side effects” as the main reason for not vaccinating. If
mothers are making the decisions about vaccinations for HPV then their major concerns need
to be successfully addressed by public health officials. Gender of the teen is also an important
factor to keep in mind when evaluating the reasons for not vaccinating. Male teens were 20%
more likely to not vaccinate because vaccine was not recommended and 39% more likely to not
vaccinate because of lack of knowledge. Having a mother with higher education means that
“safety concerns/side effects” are main reasons for not vaccinating for HPV. In contrast having
a mother with a high school level or lower education means the reason for not vaccinating is
due to lack of vaccine recommendation and lack of knowledge. This finding is in alignment with
what was found in previous research and shows that those electing not to vaccinate for HPV
tend to be mothers with higher education. Another important finding is that those with higher
education did not cite lack of knowledge as a reason, instead they were less likely to indicate
not vaccinating because of lack of knowledge. Mothers with higher education had safety
concerns but still did not indicated they have lack of knowledge about HPV vaccines. Future
research efforts should consider exploring the rational for the concern about safety/side effects
for HPV vaccination among mothers with higher education. Further investigation is warranted
for understanding what “lack of knowledge” means to parents. Does it mean they have no idea
what HPV vaccines are meant to protect their child from? Or is it that they have heard of the
vaccine but would like more information? These and similar questions should be explored for

those who indicated “lack of knowledge” was the main reason for not vaccinating for HPV.
Additional research should focus on those who are not vaccinating and attempt to identify best
methods to address concerns for these populations.
Limitations of this study include the inability to generalize any of these findings beyond
the region that was studied. Because the NIS-Teen data is a cross-sectional survey it is not
generalizable over different periods of time. Household surveys may include recall bias because
respondents were asked questions about events in the past (has the teen ever received HPV
vaccination). Those who refused to respond to the questions were not included in the analysis
and there could be something unique about those that refused that could have influenced their
decisions about HPV vaccines. Future efforts should consider looking at those who refused the
questions about vaccinating for HPV and compare them with the group that did respond to see
if variances among the groups exist. Differences in attitudes towards HPV vaccination by states,
by different health departments and by providers can influence decisions parents make to
vaccinate for HPV. This, in turn, can be a confounding variable impacting findings in this study.
The variables available in the NIS-Teen 2016 dataset do not account for these other potentially
influential factors. The overall burden of disease for HPV in the population may be understated
as most cases are latent.

5.2 Implications of Findings & Recommendations
Public health efforts around HPV vaccination and education should focus on mothers
with higher education levels. In addition, the interventions should be centered around
educating mothers about the safety of the HPV vaccine. Mothers with less than high school
education should also be targeted with public health efforts to improve knowledge about HPV

vaccination. Providers should be educated about the importance of making consistent
recommendations for all their clients and follow all ACIP guidelines. Providers need to
recommend HPV vaccination for mothers with less than high school education and boys more
consistently. The public has a limited understanding of how the human immune system works
and the ways in which vaccines interact with the natural immune response to induce protection
against vaccine preventable diseases. HPV vaccine education should focus on efforts to alleviate
the concerns about safety and side effects. Education efforts need to be targeted to those who
are not vaccinating. Providers need to be educated on how to: 1) address concerns from
parents about safety/side effects, 2) handle resistance from parents who feel vaccinating for
HPV is not need or not necessary, 3) make consistent recommendations across all patient
populations, and provide resources for those who lack knowledge. Public health must also
support the efforts of providers by disseminating accurate and timely information about the
need to vaccinate every child with HPV vaccine.
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Appendix
Table 4: Odds Ratio Estimates for Reason “Not Needed/Not Necessary”
Sociodemograpic Factor
Point Estimate
95% Wald Confidence Limits
Gender of Teen
Female
Male
Mother’s Age
≤34 Years
35 – 44 Years
≥45 Years
Mother’s Education Level
≤ high school
>12 yrs non-college
College graduate
Number of Children <18 Years in Household
4 or more
One only
Two or three
Relationship of Respondent to Teen
Father/male guardian
Mother/female guardian
Race/Ethnicity of Teen
Black
White
Hispanic

1.0
1.12

-0.97 - 1.29

1.0
0.74
0.80

-0.57 - 0.96
0.61- 1.05

1.0
1.21
1.16

-0.99 - 1.47
0.96 - 1.39

1.0
1.0
1.11

-0.77 - 1.30
0.87 - 1.41

1.0
0.83

-0.72 - 0.97

1.0
0.93
0.79

-0.77 - 1.12
0.61 - 1.01

Table includes reference groups (1.0) for each sociodemogrpahic factor included in the model. Bolded values indlicate statistical significance.

Table 5: Odds Ratio Estimates for Reason “[Vaccine] Not Recommended”
Sociodemograpic Factor
Point Estimate
95% Wald Confidence Limits
Gender of Teen
Female
Male
Mother’s Age
≤34 Years
35 – 44 Years
≥45 Years
Mother’s Education Level
≤ high school
>12 yrs non-college
College graduate
Number of children <18 Years in Household
4 or more
One only
Two or three
Relationship of Respondent to Teen
Father/male guardian
Mother/female guardian
Race/Ethnicity of Teen
Black
White
Hispanic

1.0
1.21

-1.03 - 1.42

1.0
1.17
1.33

-0.86 - 1.59
0.96 - 1.82

1.0
0.80
0.63

-0.65 - 0.98
0.52 - 0.76

1.0
0.87
0.87

-0.66 - 1.15
0.67 - 1.13

1.0
0.65

-0.55 - 0.76

1.0
0.85
1.00

-0.68 - 1.05
0.77 - 1.31

Table includes reference groups (1.0) for each sociodemogrpahic factor included in the model. Bolded values indlicate statistical significance.

Table 6: Odds Ratio Estimates for Reason “Safety Concerns/Side Effects”
Sociodemograpic Factor
Point Estimate
95% Wald Confidence Limits
Gender of Teen
Female
Male
Mother’s Age
≤34 Years
35 – 44 Years
≥45 Years
Mother’s Education Level
≤ high school
>12 yrs non-college
College graduate
Number of children <18 Years in houshold
4 or more
One only
Two or three
Relationship of respondent to teen
Father/male guardian
Mother/female guardian
Race/Ethnicity of teen
Black
White
Hispanic

1.0
0.64

-0.55 - 0.74

1.0
1.31
1.07

-0.95 - 1.81
0.77 - 1.50

1.0
1.39
1.45

-1.11 - 1.74
1.17 - 1.79

1.0
0.86
0.87

-0.65 - 1.13
0.68 - 1.13

1.0
2.05

-1.70 - 2.46

1.0
1.49
0.86

-1.19 - 1.86
0.65 - 1.18

Table includes reference groups (1.0) for each sociodemogrpahic factor included in the model. Bolded values indlicate statistical significance.

Table 7: Odds Ratio Estimates for Reason “Lack of Knowledge”
Sociodemograpic Factor
Point Estimate
Gender of Teen
Female
Male
Mother’s Age
≤34 Years
35 – 44 Years
≥45 Years
Mother’s Education Level
≤ high school
>12 years non-college
College graduate
Number of children <18 Years in houshold
4 or more
One only
Two or three
Relationship of respondent to teen
Father/male guardian
Mother/female guardian
Race/Ethnicity of Teen
Black
White
Hispanic

95% Wald Confidence Limits

1.0
1.39

-1.16 - 1.67

1.0
0.98
0.84

--0.71 - 1.37
0.60 - 1.20

1.0
0.71
0.57

-0.56 - 0.89
0.46 - 0.71

1.0
1.87
1.70

-1.29 - 2.72
1.19 - 2.43

1.0
0.828

-0.69 - 0.99

1.0
0.81
0.99

-0.64 - 1.03
0.74 - 1.33

Table includes reference groups (1.0) for each sociodemogrpahic factor included in the model. Bolded values indlicate statistical significance.

